Status:
COMPLETED
Health Benefits of Repeated Treatment in Pediatric Schistosomiasis
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
University of Zimbabwe
Conditions:
Schistosomiasis
Eligibility:
All Genders
1-10 years
Brief Summary
Objective and Hypotheses: This project has the overall objective of implementing and evaluating new approaches to reducing the current and future burden of urinary schistosomiasis in young children us...
Detailed Description
This study aims to address the present health inequity by refinement of an existing drug regimen to improve the current and future health of pre-school children and infants. Praziquantel is cheap, hig...
Eligibility Criteria
Inclusion
- lifelong residents of the area
- have provided at least 2 urine and 2 stool for parasitological examination
- have given a blood sample before and after each treatment episode
- be negative for hookworm, Trichuris and Ascaris
Exclusion
- clinical signs of tuberculosis or malaria
- presenting with fever
- have had a recent major operation, illness or vaccination
- have previously received antihelminthic treatment
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT01424410
Start Date
February 1 2012
End Date
November 1 2014
Last Update
June 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes for Health Research
Harare, Zimbabwe